Introduction:Telemedicine is a follow-up system that can improve the quality of management and cost-effectiveness of rapidly increasing diabetes patients. Methods:Two hundred adult patients with diabetes were enrolled in this prospective, randomized study. Consecutive patients were divided equally into two groups. Both groups received routine care visits quarterly. TeleDiab group also sent self-monitoring of blood glucose data and received short message service over the transmission system for 12 months. After the study was completed, all patients continued their routine care visits, and their data were evaluated for another 12 months. Six years after the initial study, patients were contacted by phone during the Covid-19 lockdown, and their status was assessed. Results:At the end of the study, glycemic control, kidney function, and lipid parameters of the TeleDiab group were statistically significantly better than the Usual Care group. There was no significant change in the weights of the patients. It was observed that this state of wellbeing continued both at the end of the second year and during the Covid-19 lockdown. Individuals with type 2 diabetes were found to benefit more from telemedicine. Discussion:It has been beneficial to guide patients with applications such as TeleDiab in diseases such as diabetes that require lifelong follow-up. On the other hand, the importance of telemedicine programs in the management of chronic diseases in the current pandemic conditions has come to the fore even more. Telemedicine is an effective motivational tool to ensure optimal control not only of glycemic but also of kidney and lipid parameters.

Background and objective: Although many studies on the Diabetes Eating Problem Survey–Revised (DEPS-R) in adolescents with type 1 diabetes mellitus (T1D), the number of studies validating this questionnaire in adults with T1D is limited. Therefore, this study aimed to examine the factor structure of the Turkish version of the DEPS-R in adults with T1D and internal consistency and construct validity. Methods: A total of 100 patients with T1D, ages 18–50 years, completed the DEPS-R and EDE-Q. In addition to tests of validity, confirmatory factor analysis was conducted to investigate the factor structure of the 6-item Turkish version of DEPS-R. Results: The Cronbach’s alpha coefficient of the DEPS-R Turkish version was 0.77, suggesting good internal consistency. The median (IQ) DEPS-R score was 15.0 (13.0) among all participants. DEPS-R score was significantly correlated with BMI (r = 0.210; p < 0.05) and EDE-Q (r = 0.586; p < 0.01). There was no correlation between the HbA1c values of participants and neither EDE-Q nor DEPS-R scores. The confirmatory factor analysis results show that the three-factor model was a good fit. Conclusion: A short, self-administered diabetes-specific screening tool for disordered eating behavior is recommended be used routinely in the clinical care of adults with T1D, and Turkish version of DEPS-R has acceptable internal consistency and construct validity in adults with T1D. Level of evidence: Level V, descriptive study. Clinicaltrials.gov registration number NCT05346679/ 21.04.2022 (retrospectively registered)

İstanbul Üniversitesi Yayın Projesi

Objective: Smoking, caffeine, oral contraception, and exercise are the most cited factors for premenstrual mastalgia in the literature, but remain controversial. In this study, we aimed to investigate the most often proposed nutritional factors for cyclic breast pain. Materials and Methods: Patients who met the criteria for participation in the mastalgia or control group were included in this case-control study. The age, body mass index, educational status, duration of breast pain, visual analog scale (VAS) pain score (0 to 10), number of births, use of oral contraception, exercise habits, drinking coffee, tea, alcohol and water, smoking history, and eating fast food and dessert were examined using a questionnaire. Results: The mean age of mastalgia (n=256) and control (n=200) patients were 35.9 +/- 11.0 and 36.6 +/- 10.6 years, respectively. In the mastalgia group, the mean duration of cyclic breast pain time was 22.8 +/- 33.0 months and mean the VAS score 4.0 +/- 2.1. Body mass index and the mean number of births were higher in the mastalgia group than control group (p0.005). Compared to the mastalgia group, the control group ate more fast food and desserts, drank more water and coffee, and exercised less (p<0.005). Conclusion: The causes of mastalgia remain controversial. Our data supports some of the published studies, but not others. We propose that nutritional factors contribute less to the risk of mastalgia than is generally thought.

Amaç: Bu çalışma diabetes mellitus nedeniyle izlenen hastalarda kan şekeri ölçüm sıklığı ile diyabet regülasyonu ve diyabetin komplikasyonları arasındaki ilişkiyi belirlemek amacıyla yapılmıştır. Bireyler ve Yöntem: Çalışma 951 diyabetli hastanın (tip1= 90, tip2= 861) dosyalarının retrospektif olarak incelenmesi ile gerçekleştirilmiştir. Hastaların yaşı, cinsiyeti, boyu, ağırlığı, diyabet tipi, diyabet süresi, diyabet tedavisi, hemoglobin A1c (HbA1c) değeri, nöropati varlığı, nefropati varlığı, diyabetik ayak varlığı, hipertansiyon varlığı, kan şekeri ölçüm sıklığı bilgileri not edilmiştir. Kan şekeri ölçüm sıklıklarına göre hastalar 3 gruba ayrılmıştır: haftada en az iki gün toplam 8 kez kan şekeri ölçümü yapanlar (grup 1), haftada iki günden az ve 8 ölçümden az kan şekeri ölçümü yapanlar (grup 2), düzensiz kan şekeri ölçümü yapmalarına rağmen doktor kontrolüne gelmeden önceki 2 gün içerisinde 8 kez kan şekeri ölçümü yapanlar (grup 3). Bulgular: Hastaların 548’i kadın, 403’ü erkek, ortalama yaş 58.12±13.17 yıldır. Gruplar arasında HbA1c (p<0.001) ve diyabet süresi (p<0.001) parametrelerinde anlamlı fark belirlenmiştir. Hastaların kan şekeri ölçüm sıklığı ile diyabet tipi (p<0.001), diyabet tedavi şekli (p<0.001), retinopati varlığı (p<0.001), nefropati varlığı (p<0.001), hipertansiyon varlığı (p<0.001) arasında anlamlı bir fark olduğu saptanmıştır. Sonuç: Doğru ölçüm tekniği ve güvenilir kan şekeri ölçüm aletleri ile yapılan kan şekeri ölçümü, hastanın diyabeti tanıması ve yönetmesine imkân tanımakla birlikte diyabete bağlı gelişebilecek komplikasyonların önüne geçilmesinde yardımcı olmaktadır.